Pilot Study: Clinical Trial Task Ontology Development. A prototype ontology of common participant-oriented clinical research tasks and

Size: px
Start display at page:

Download "Pilot Study: Clinical Trial Task Ontology Development. A prototype ontology of common participant-oriented clinical research tasks and"

Transcription

1 Pilot Study: Clinical Trial Task Ontology Development Introduction A prototype ontology of common participant-oriented clinical research tasks and events was developed using a multi-step process as summarized in this section and illustrated in 1. Figure 1: Overview of the workflow used to create an ontology of common clinical trial tasks and events. The figure illustrates the knowledge sources, processes, and resulting intermediate and final knowledge collections used or created during this workflow. Methodology Step 1. A convenience sample of Phase I-III therapeutic clinical trial protocol documents targeting multiple treatment areas were drawn from both the Columbia University

2 Clinical Trials Network (CTN) and Chronic Lymphocytic Leukemia Research Consortium (CLLRC). These protocol documents were manually evaluated, and those tasks or events that satisfied the following two criteria were abstracted: i. The task or event was participant-centric (i.e., described an activity which pertained or was applied to the research participant), and would yield one or more elements of either quantitative or qualitative data. ii. The task or event occurred during the active phase of the protocol, which was defined as the time frame after initial screening and eligibility assessment (i.e., after the completion of all therapeutic interventions), but prior to long-term follow-up. Whenever possible, these tasks and events were abstracted from temporal grids found in the protocol documents. Step 2. Each event or task abstracted from the protocol documents was mapped to a unique UMLS concept using the free-text search engine available via the UMLS Knowledge Source (UMLSKS) server ( For those tasks or events that did not result in an exact match using this approach, one of the following strategies was used to assign an adequate UMLS concept: i. For compound concepts (e.g., height and weight measurement ), the text was decomposed to the smallest semantically significant units (e.g., height, weight ) and the free-text matching algorithm was then applied to each component. The UMLS concepts found via this process were then subject to post-coordination.

3 ii. Any possible synonyms provided via the free-text matching algorithm were explored, and if a suitable semantic match was found, that concept was selected for the purposes of generating a matching UMLS concept. The resulting collection of unique UMLS concepts, identified by Concept Unique Identifiers (CUI s), with associated occurrence frequencies at the protocol, treatment and aggregate levels were recorded for later use and analysis. Step 3. A composite support metric [1] (S A ) for each unique UMLS concept was calculated based upon a summation of support statistics incorporating the protocol, treatment and aggregate level occurrence frequencies (Equation 1). S A = n + p t n t + g p t g Equation 1: Composite support (S A ) for a given concept (A), where n is the total number of occurrences of concept A, t n is the total number of all concept occurrences, p is the number of protocols in which concept A occurs, t p is the total number of protocols, g is the number of treatment groups is which concept A occurs, and t g is the total number of treatment groups. Step 4. The unique concepts in the corpus were rank-ordered in descending order based upon the their respective S A values. Those concepts that composed 95% of the total number of instances given the preceding rank order were selected for subsequent inclusion in a prototype clinical trial task ontology. Step 5. Five subjects with backgrounds in the conduct of clinical research (e.g., physicians, nurses, study coordinators/managers) were recruited from the Columbia

4 University Medical Center. They each performed an all-in-one card sort of the selected concepts using a Web-based application ( where they were able to view a list of the concepts and place those concepts into groups based upon the similarity of their meanings or any other sorter-selected criteria. The subjects were also asked to provide descriptive names for each group created during the sorting process. Step 6. The results of the card sort were represented using a symmetric agreement matrix where each cell was assigned a numerical score indicating the number of sorters who placed the two concepts indicated by the column and row indices together in a group. The agreement matrix was then analyzed using several techniques, as described in Steps 7-9. Step 7. Agreement statistics were calculated to determine how many sorters agreed on each possible pair-wise grouping of a concept with all remaining concepts. Step 8. Hierarchical cluster analysis was performed, using an average linkage algorithm as implemented in the JMP 5.0.1a statistics package [2] to generate consensus clusters of the sorted concepts. Step 9. Thematic analysis was performed to assess the high-level group names assigned to the concepts that comprised each consensus cluster. To enable this analysis, each group name assigned by the sorters was manually mapped to a semantically similar UMLS concept (using the same method as described in Step 2), thus providing a

5 consistent nomenclature across sorters. The results of this thematic analysis were then used to organize the subsumed concepts into a basic ontology using parent-child relationships. Results Task and Event Abstraction As described earlier, a convenience sample of 32 Phase I-III therapeutic protocols were selected from the library of protocols currently available within the Columbia University Clinical Trials Network (CTN) and the Chronic Lymphocytic Leukemia Research Consortium (CLLRC). The source organizations of these protocols were masked to prevent the disclosure of any proprietary sponsor information regarding therapeutic agent names. The protocols could be generally classified according to one of six major treatment groups: Endocrine, Gastrointestinal (GI), Hypertension, Neurology, Oncology and Vascular Disease. The distribution of protocols by treatment group is shown in Figure 2.

6 Hypertension (n=1) 3% Vascular (n=2) 6% Endocrine (n=3) 9% Oncology (n=17) Neurology (n=3) 9% GI (n=6) 19% Figure 2: Distribution of protocols used to develop clinical trial task ontology by treatment group. From the 32 selected protocols, a total of 522 task or event instances satisfying the criteria enumerated earlier, were abstracted and mapped to UMLS concepts. This process yielded 93 unique concepts identified by UMLS CUI s, and a corresponding set of concept instances indicating how often that unique concept occurred within the overall set of 522 tasks or events. A composite support metric (S A ) (Equation 1) was calculated for each unique concept, and the resulting values fell between 0.19 and 2, with an average of 0.46 ± 0.4. The concepts were then arranged in a descending rank order according to the value of the corresponding composite support metric. A threshold value for S A was set by selecting the point in the rank ordering at which 95% of the initial 522 task or event instances were represented. This threshold was found to be 0.19 (Figure 3).

7 2 1.8 S A = % 90.00% % % 70.00% 60.00% 50.00% 40.00% 30.00% Percent of Total Concept Instances % % Number of Concepts 0.00% Composite Support Percent of Total Concept Instances Figure 3: Distribution of composite support metric (S A ) by unique UMLS concept versus contribution to overall number of task and event instances. Those unique UMLS concepts with a support metric equal to or greater than the threshold value were selected for subsequent inclusion in the prototype clinical trial task ontology, resulting in a set of 67 concepts (Table 1). Table 1: Concepts selected for use in prototype clinical trial task and event ontology. UMLS Concept Name Composite Support Metric % of Total Concept Instances (n = 522) Clinical Examination Medical History Electrocardiogram Hematology Blood Chemical Analysis

8 UMLS Concept Name Composite Support Metric % of Total Concept Instances (n = 522) Adverse Effects Inclusion and Exclusion Dispensing Medication Obtain or Verify Patient s Informed Consent Laboratory Procedures Pregnancy Tests Vital Signs Urinalysis Patient Outcome Assessment Drug Compliance Checked Blood Pressure Determination Biological Markers Demographics Random Allocation Blood Specimen Collection Pulse Rate Body Weight Bone Marrow Biopsy Assessment Procedure Radiography, Thoracic Drug Kinetics Genotype Determination Glycosylated Hemogolobin A Beta-2-microglobulin Measurement Partial Thromboplastin Time Flow Cytometry Screening Procedure Intravascular HCV RNA, QUAL

9 UMLS Concept Name ASSAY (PCR) Test Composite Support Metric % of Total Concept Instances (n = 522) Biopsy of Liver Immunoglobulin Measurement Questionnaires Therapeutic Procedure Measurement Lymphocyte Marker Ophthalmic Examination and Evaluation Thyroid Stimulating Hormone Measurement Status Polymerase Chain Reaction Cytomegalovirus Neoplasms Alpha One Fetoprotein Measurement Test, Lipids Profile Glucose Measurement, Fasting Phospholipids Quality of Life X-Ray Computed Tomography Urine Specimen Collection Creatinine Measurement Electrolytes Measurement Early Morning Urine Sample Waist Circumference Registration Procedure Diagnostic Radiologic Examination and Procedures Phlebotomy

10 UMLS Concept Name Composite Support Metric % of Total Concept Instances (n = 522) Blood Coagulation Tests Diet Echocardiography Endoscopy Insulin Leukapheresis Lymph Nodes Oral Glucose Tolerance Test Card Sorting After the selection of the preceding concept set, five subjects were recruited to participate in a card sorting study using those concepts. The four female and one male subjects ranged in age from 30 to 57 years old (average age = 42). All but one of the subjects had a graduate level education within the areas of nursing, physiology or public health. All of the subjects had significant experience in the area of clinical research (on average 18 years), serving as either research staff (e.g., study coordinator, data manager, research nurse) or clinical investigators. Using a three-category scale consisting of novice, occasional and expert, four subjects identified themselves as expert computer users, and the remaining subject was self-identified as an occasional computer user. These participants conducted an all-in-one card sort of the concept set, creating groups of concepts they considered to be similar and providing names for those groups. This card sort was performed using the Websort [3] Web application (Figure 4).

11 Figure 4: Example of the Websort web application interface, used to perform an all-in-one card sort of clinical trial task and event concepts. The participants in the card sorting study created 47 unique groups, ranging in size from 1 to 33 concepts, with an average size of 6.9 ± 7 (Figure 5). The observed aggregate agreement was 79.9 ± 13.6 %. In comparison, the predicted aggregate agreement generated using the Simulated Agreement Matrix (SAM) application, was found to be 5.2 ± 9.9 %. The average magnitude of difference between the observed and predicted aggregate agreement was 5.2 standard deviations (Figure 6).

12 Distribution of Group Sizes Number of Groups Figure 5: Distribution of group sizes created by sorters in Sub-Study One. Observed Versus Predicted Aggregate Agreement in Sub-Study % 90.00% Observed Agreement 80.00% 70.00% 60.00% 50.00% 40.00% Average Difference = 5.2 SD 30.00% 20.00% 10.00% 0.00% Predicted Agreement Number of Concepts Figure 6: Observed versus predicted aggregate agreement in Sub-Study One.

13 Cluster Analysis Cluster analysis was performed using a hierarchical average linkage algorithm as implemented in the JMP 5.0.1a statistics package [2]. 26 consensus clusters were generated, with an average size of 3.5 ± 2.7 concepts (Figure 7). The average Euclidean distance between members of the consensus clusters was 3.89 ± 2.44, with a range of distances between 0 and 7.34 (Figure 8). Distribution of Cluster Sizes Number of Clusters Figure 7: Distribution of "consensus cluster" sizes in Sub-Study One.

14 Distribution of Cluster Distances Number of Clusters Figure 8: Distribution of the average inter-member distances in the "consensus clusters" generated during Sub-Study One. Thematic Analysis A thematic analysis of the consensus clusters of concepts in conjunction with the group names assigned to those concepts by the multiple sorters was undertaken in order to develop an organizing taxonomy of the selected concepts. On average, each consensus cluster had 7.42 ± 5.94 thematically unique group names associated with it. When those group names given to a consensus cluster two or more times were selected, there were on average 1.57 ± 1 unique group names per cluster. Several examples of these types of consensus clusters and the thematically unique group names associated with them are provided below (Table 2).

15 Table 2: Example "consensus clusters" and associated thematically unique group names from Sub-Study One. Concepts in Consensus Cluster Avg Euclidean Distance Between Concepts Thematically Unique Group Names Creatinine Measurement Electrolyte Measurement Glucose Measurement, Fasting Test, Lipids Profile 0.73 Laboratory Procedures Random Allocation Screening Procedure 1.39 Research Administrative Procedure Screening Procedure Pulse Rate Vital Signs Waist Circumference 2.12 Measurement Endoscopy Ophthalmic Examination and Evaluation 5.63 Procedures For the purposes of the ontology construction phase of this analysis, only the seven most frequently occurring thematically unique group names, corresponding to the average number of themes per consensus cluster, were selected for use in organizing the concepts from the initial selected set. These group names are enumerated in Table 3.

16 Table 3: Seven most common thematically unique group names and number of occurrences associated with "consensus clusters" generated during Sub-Study One. Theme Name Occurrences % of Consensus Clusters (n = 26) Subsumed Concepts % of Initial Concept Set (n = 67 ) Laboratory Procedures 11 (42%) 44 (66%) Research Administrative Procedures 10 (38%) 28 (42%) Procedures 8 (31%) 35 (52%) Screening Procedure 5 (19%) 15 (22%) Diagnostic Radiologic Examination 3 (12%) 10 (15%) Measurement 3 (12%) 15 (22%) Specimen 1 (4%) 10 (15%) Ontology Construction Given the preceding consensus clusters and associated thematic analysis results, a simple prototype ontology was constructed using parent-child relationships. These relationships were instantiated by assigning the seven unique group name concepts selected via thematic analysis the role of parents, and all of the other subsumed concepts from the initial concept set the role of children. Multiple-hierarchies, cases where a child has more than one parent, were allowed in this ontology. The resulting ontology construct was formalized using an ancestor-descendant table (Appendix J), and visualized using the open-source GraphViz application [4] (Figures 9 and 10).

17 Figure 9: Visualization of prototype clinical trial task and event ontology, showing concepts with the parents Measurement and/or Procedures.

18 Figure 10: Visualization of prototype clinical trial task and event ontology, showing concepts with the parents Research Administrative Procedures and/or Screening Procedure.

19 References 1. Han, J. and M. Kamber, Data mining: concepts and techniques. 2001, San Diego: Academic Press SAS, JMP. 1999, SAS. 3. Wood, L.E., WebSort Low, G., graphviz. 2006, pixelglow.

Answers to end of chapter questions

Answers to end of chapter questions Answers to end of chapter questions Chapter 1 What are the three most important characteristics of QCA as a method of data analysis? QCA is (1) systematic, (2) flexible, and (3) it reduces data. What are

More information

Chapter 1. Introduction

Chapter 1. Introduction Chapter 1 Introduction 1.1 Motivation and Goals The increasing availability and decreasing cost of high-throughput (HT) technologies coupled with the availability of computational tools and data form a

More information

SAGE. Nick Beard Vice President, IDX Systems Corp.

SAGE. Nick Beard Vice President, IDX Systems Corp. SAGE Nick Beard Vice President, IDX Systems Corp. Sharable Active Guideline Environment An R&D consortium to develop the technology infrastructure to enable computable clinical guidelines, that will be

More information

Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials

Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials Riccardo Miotto and Chunhua Weng Department of Biomedical Informatics Columbia University,

More information

Mipomersen (ISIS ) Page 2 of 1979 Clinical Study Report ISIS CS3

Mipomersen (ISIS ) Page 2 of 1979 Clinical Study Report ISIS CS3 (ISIS 301012) Page 2 of 1979 2 SYNOPSIS ISIS 301012-CS3 synopsis Page 1 Title of Study: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics,

More information

Stepwise Knowledge Acquisition in a Fuzzy Knowledge Representation Framework

Stepwise Knowledge Acquisition in a Fuzzy Knowledge Representation Framework Stepwise Knowledge Acquisition in a Fuzzy Knowledge Representation Framework Thomas E. Rothenfluh 1, Karl Bögl 2, and Klaus-Peter Adlassnig 2 1 Department of Psychology University of Zurich, Zürichbergstraße

More information

PFIZER INC. These results are supplied for informational purpose only. Prescribing decisions should be made based on the approved package insert.

PFIZER INC. These results are supplied for informational purpose only. Prescribing decisions should be made based on the approved package insert. Public Disclosure Synopsis Protocol A3924 4 November 24 Final PFIZER INC. These results are supplied for informational purpose only. Prescribing decisions should be made based on the approved package insert.

More information

CHAPTER 3 RESEARCH METHODOLOGY

CHAPTER 3 RESEARCH METHODOLOGY CHAPTER 3 RESEARCH METHODOLOGY 3.1 Introduction 3.1 Methodology 3.1.1 Research Design 3.1. Research Framework Design 3.1.3 Research Instrument 3.1.4 Validity of Questionnaire 3.1.5 Statistical Measurement

More information

A Simple Pipeline Application for Identifying and Negating SNOMED CT in Free Text

A Simple Pipeline Application for Identifying and Negating SNOMED CT in Free Text A Simple Pipeline Application for Identifying and Negating SNOMED CT in Free Text Anthony Nguyen 1, Michael Lawley 1, David Hansen 1, Shoni Colquist 2 1 The Australian e-health Research Centre, CSIRO ICT

More information

Investigator Qualification Evidence Gathering: Our Approach to Data Collection

Investigator Qualification Evidence Gathering: Our Approach to Data Collection December 13, 2017 Investigator Qualification Evidence Gathering: Our Approach to Data Collection Teri Swezey, PhD, MA. CTTI Assistant Social Scientist. Project Leader, Duke SOM Overview Brief review of:

More information

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up.

HOVON 141 CLL. Version 3, 25JUL2018. Table Required investigations at entry, during treatment and during follow up. Table 10.2.1 Required investigations at entry, during treatment and during follow up At entry 1 each induction cycle cycle 2 Cycle 3 day 8 and 15 Cycle 4 day1 and 6 cycle 9 day 15 of cycle 15 9 cycle 15:

More information

Ontology Development for Type II Diabetes Mellitus Clinical Support System

Ontology Development for Type II Diabetes Mellitus Clinical Support System Ontology Development for Type II Diabetes Mellitus Clinical Support System Nopphadol Chalortham 1, Marut Buranarach 2 and Thepchai Supnithi 2 1 Department of Health-Related Informatics of Pharmacy, Silpakorn

More information

TITLE: A Data-Driven Approach to Patient Risk Stratification for Acute Respiratory Distress Syndrome (ARDS)

TITLE: A Data-Driven Approach to Patient Risk Stratification for Acute Respiratory Distress Syndrome (ARDS) TITLE: A Data-Driven Approach to Patient Risk Stratification for Acute Respiratory Distress Syndrome (ARDS) AUTHORS: Tejas Prahlad INTRODUCTION Acute Respiratory Distress Syndrome (ARDS) is a condition

More information

Recognizing Scenes by Simulating Implied Social Interaction Networks

Recognizing Scenes by Simulating Implied Social Interaction Networks Recognizing Scenes by Simulating Implied Social Interaction Networks MaryAnne Fields and Craig Lennon Army Research Laboratory, Aberdeen, MD, USA Christian Lebiere and Michael Martin Carnegie Mellon University,

More information

Semi-Automatic Construction of Thyroid Cancer Intervention Corpus from Biomedical Abstracts

Semi-Automatic Construction of Thyroid Cancer Intervention Corpus from Biomedical Abstracts jsci2016 Semi-Automatic Construction of Thyroid Cancer Intervention Corpus from Biomedical Wutthipong Kongburan, Praisan Padungweang, Worarat Krathu, Jonathan H. Chan School of Information Technology King

More information

A Comparison of Collaborative Filtering Methods for Medication Reconciliation

A Comparison of Collaborative Filtering Methods for Medication Reconciliation A Comparison of Collaborative Filtering Methods for Medication Reconciliation Huanian Zheng, Rema Padman, Daniel B. Neill The H. John Heinz III College, Carnegie Mellon University, Pittsburgh, PA, 15213,

More information

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data

Breast cancer. Risk factors you cannot change include: Treatment Plan Selection. Inferring Transcriptional Module from Breast Cancer Profile Data Breast cancer Inferring Transcriptional Module from Breast Cancer Profile Data Breast Cancer and Targeted Therapy Microarray Profile Data Inferring Transcriptional Module Methods CSC 177 Data Warehousing

More information

MAPS Study MP-10 1 Study Synopsis UK April 18, 2011

MAPS Study MP-10 1 Study Synopsis UK April 18, 2011 MAPS Study MP-10 1 Study Synopsis A Randomized, Triple-Blind, Phase 2 Pilot Study with an Open-Label Lead-in Comparing 3 Different Doses of MDMA in Conjunction with Manualized Psychotherapy in 20 Subjects

More information

PhRMA Clinical Study Synopsis Protocol CTN / (A /A ) 21 August 2006 Final PFIZER INC.

PhRMA Clinical Study Synopsis Protocol CTN / (A /A ) 21 August 2006 Final PFIZER INC. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.

More information

FAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated

FAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly

More information

Selecting a research method

Selecting a research method Selecting a research method Tomi Männistö 13.10.2005 Overview Theme Maturity of research (on a particular topic) and its reflection on appropriate method Validity level of research evidence Part I Story

More information

CHAPTER 4 THE QUESTIONNAIRE DESIGN /SOLUTION DESIGN. This chapter contains explanations that become a basic knowledge to create a good

CHAPTER 4 THE QUESTIONNAIRE DESIGN /SOLUTION DESIGN. This chapter contains explanations that become a basic knowledge to create a good CHAPTER 4 THE QUESTIONNAIRE DESIGN /SOLUTION DESIGN This chapter contains explanations that become a basic knowledge to create a good questionnaire which is able to meet its objective. Just like the thesis

More information

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY)

Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY) A service of the U.S. National Institutes of Health Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY) This study is currently recruiting participants.

More information

Causal Knowledge Modeling for Traditional Chinese Medicine using OWL 2

Causal Knowledge Modeling for Traditional Chinese Medicine using OWL 2 Causal Knowledge Modeling for Traditional Chinese Medicine using OWL 2 Peiqin Gu College of Computer Science, Zhejiang University, P.R.China gupeiqin@zju.edu.cn Abstract. Unlike Western Medicine, those

More information

Mining Human-Place Interaction Patterns from Location-Based Social Networks to Enrich Place Categorization Systems

Mining Human-Place Interaction Patterns from Location-Based Social Networks to Enrich Place Categorization Systems Mining Human-Place Interaction Patterns from Location-Based Social Networks to Enrich Place Categorization Systems Yingjie Hu, Grant McKenzie, Krzysztof Janowicz, Song Gao STKO Lab, Department of Geography,

More information

Zainab M. AlQenaei. Dissertation Defense University of Colorado at Boulder Leeds School of Business Operations and Information Management Division

Zainab M. AlQenaei. Dissertation Defense University of Colorado at Boulder Leeds School of Business Operations and Information Management Division An Investigation of the Relationship between Consumer Mental Health Recovery Indicators and Clinicians Reports Using Multivariate Analyses of the Singular Value Decomposition of a Textual Corpus Zainab

More information

DEMOGRAPHICS PHYSICAL ATTRIBUTES VITAL SIGNS. Protocol: ABC-123 SCREENING. Subject ID. Subject Initials. Visit Date: / / [ YYYY/MM/DD]

DEMOGRAPHICS PHYSICAL ATTRIBUTES VITAL SIGNS. Protocol: ABC-123 SCREENING. Subject ID. Subject Initials. Visit Date: / / [ YYYY/MM/DD] SCREENING Visit Date: DEMOGRAPHICS / / [YYYY/MM/DD] Consent Signed Date and time / / [YYYY/MM/DD] : Has written assent been obtained? If no, why not? YES NO Gender: Male Female Birthdate: Permission given

More information

SUMMARY. Research hypotheses:

SUMMARY. Research hypotheses: SUMMARY Nephrotic syndrome is one of the most, chronic kidney disease in Egypt. The estimated incidence of nephrotric syndrome ranges between 2-7 childhood cases per 100,000 children per year. Childhood

More information

Oncotype DX testing in node-positive disease

Oncotype DX testing in node-positive disease Should gene array assays be routinely used in node positive disease? Yes Christy A. Russell, MD University of Southern California Oncotype DX testing in node-positive disease 1 Validity of the Oncotype

More information

Cognitive Maps-Based Student Model

Cognitive Maps-Based Student Model Cognitive Maps-Based Student Model Alejandro Peña 1,2,3, Humberto Sossa 3, Agustín Gutiérrez 3 WOLNM 1, UPIICSA 2 & CIC 3 - National Polytechnic Institute 2,3, Mexico 31 Julio 1859, # 1099-B, Leyes Reforma,

More information

EHR Usability Test Report

EHR Usability Test Report EHR Usability Test Report Product: Procentive Version: 2015 Date of Usability Test: November 3, 6, 7, 9 and 10 2017 Date of Report: November 2017 Report Prepared By: Procentive Michael Rundle, Customization

More information

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. PROPRIETARY DRUG NAME / GENERIC DRUG NAME: Advil / Ibuprofen

More information

Anamnesis via the Internet - Prospects and Pilot Results

Anamnesis via the Internet - Prospects and Pilot Results MEDINFO 2001 V. Patel et al. (Eds) Amsterdam: IOS Press 2001 IMIA. All rights reserved Anamnesis via the Internet - Prospects and Pilot Results Athanasios Emmanouil and Gunnar O. Klein Centre for Health

More information

A pragmatic approach to HIV hotspot mapping in a developing country. Thursday, July 13, 2017

A pragmatic approach to HIV hotspot mapping in a developing country. Thursday, July 13, 2017 A pragmatic approach to HIV hotspot mapping in a developing country Thursday, July 13, 2017 Overview of HIV Epidemic Eastern and Southern Africa (ESA) 2016 Source: UNAIDS Estimates 2016 Distribution of

More information

ClinicalTrials.gov Protocol and Results Registration System (PRS) Receipt Release Date: 09/30/2015. ClinicalTrials.gov ID: NCT

ClinicalTrials.gov Protocol and Results Registration System (PRS) Receipt Release Date: 09/30/2015. ClinicalTrials.gov ID: NCT ClinicalTrials.gov Protocol and Results Registration System (PRS) Receipt Release Date: 09/30/2015 ClinicalTrials.gov ID: NCT01378962 Study Identification Unique Protocol ID: ML25514 Brief Title: A Study

More information

Taking Laboratory Coding for a Spin. Corrie Alvarez, CPC, CPMA, CPC-I, CEDC

Taking Laboratory Coding for a Spin. Corrie Alvarez, CPC, CPMA, CPC-I, CEDC Taking Laboratory Coding for a Spin Corrie Alvarez, CPC, CPMA, CPC-I, CEDC Agenda Overview of Laboratory Discuss Common Laboratory Terms Coding Guidelines Review Drug Testing, Anatomical Pathology Discuss

More information

Q Methodology to Measure Physician Satisfaction with Hospital Pathology Laboratory Services at a Midwest Academic Health Center Hospital

Q Methodology to Measure Physician Satisfaction with Hospital Pathology Laboratory Services at a Midwest Academic Health Center Hospital Q Methodology to Measure Physician Satisfaction with Hospital Pathology Laboratory Services at a Midwest Academic Health Center Hospital Laurie A. Gillard, MS, MT(ASCP) SBB, 1 Veronica N. Lewis, MS, MT(ASCP)

More information

Harvard-MIT Division of Health Sciences and Technology HST.952: Computing for Biomedical Scientists. Data and Knowledge Representation Lecture 6

Harvard-MIT Division of Health Sciences and Technology HST.952: Computing for Biomedical Scientists. Data and Knowledge Representation Lecture 6 Harvard-MIT Division of Health Sciences and Technology HST.952: Computing for Biomedical Scientists Data and Knowledge Representation Lecture 6 Last Time We Talked About Medical Coding Systems UMLS Today

More information

Quantitative Methods in Computing Education Research (A brief overview tips and techniques)

Quantitative Methods in Computing Education Research (A brief overview tips and techniques) Quantitative Methods in Computing Education Research (A brief overview tips and techniques) Dr Judy Sheard Senior Lecturer Co-Director, Computing Education Research Group Monash University judy.sheard@monash.edu

More information

CHAPTER 3 RESEARCH METHODOLOGY. In this chapter, research design, data collection, sampling frame and analysis

CHAPTER 3 RESEARCH METHODOLOGY. In this chapter, research design, data collection, sampling frame and analysis CHAPTER 3 RESEARCH METHODOLOGY 3.1 Introduction In this chapter, research design, data collection, sampling frame and analysis procedure will be discussed in order to meet the objectives of the study.

More information

Classification of normal and abnormal images of lung cancer

Classification of normal and abnormal images of lung cancer IOP Conference Series: Materials Science and Engineering PAPER OPEN ACCESS Classification of normal and abnormal images of lung cancer To cite this article: Divyesh Bhatnagar et al 2017 IOP Conf. Ser.:

More information

Cycle 1-6 (28 Days) Days 15&16 1&2 8. (±2 Days) (±2 Days) (±7 Days) (+7 days) X X X X X X X

Cycle 1-6 (28 Days) Days 15&16 1&2 8. (±2 Days) (±2 Days) (±7 Days) (+7 days) X X X X X X X Table 5 Schedule of Assessments A Cycles A-D and Cycles 1-6 (AZD4573 Monotherapy) Assessment Screen a Intra-subject Dose Escalation/ramp -up (Cycles a-d Cycle=14 days) z Days 1, 2, 15 & 16 Visits 1&2 8

More information

Required Syllabus Information all must be included in the course syllabus

Required Syllabus Information all must be included in the course syllabus Effective Implementation date: Summer 2018, 201910 Required Syllabus Information all must be included in the course syllabus BIO 202 Course Title: Human Anatomy and Physiology II with Lab:GT-SC1 Course

More information

How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes

How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes HARVARD MEDICAL SCHOOL How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes Richard W. Grant MD MPH Endocrine Society Beta Cell meeting January 9-10, 2009 Outline Background Observed

More information

The diagnosis of Chronic Pancreatitis

The diagnosis of Chronic Pancreatitis The diagnosis of Chronic Pancreatitis 1. Background The diagnosis of chronic pancreatitis (CP) is challenging. Chronic pancreatitis is a disease process consisting of: fibrosis of the pancreas (potentially

More information

Clinical decision support (CDS) and Arden Syntax

Clinical decision support (CDS) and Arden Syntax Clinical decision support (CDS) and Arden Syntax Educational material, part 1 Medexter Healthcare Borschkegasse 7/5 A-1090 Vienna www.medexter.com www.meduniwien.ac.at/kpa (academic) Better care, patient

More information

Education and Training Committee 15 November 2012

Education and Training Committee 15 November 2012 Education and Training Committee 15 November 2012 Review of the process of approval of hearing aid dispenser pre-registration education and training programmes. Executive summary and recommendations Introduction

More information

Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD

Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Case Studies on High Throughput Gene Expression Data Kun Huang, PhD Raghu Machiraju, PhD Department of Biomedical Informatics Department of Computer Science and Engineering The Ohio State University Review

More information

A Method for Analyzing Commonalities in Clinical Trial Target Populations

A Method for Analyzing Commonalities in Clinical Trial Target Populations A Method for Analyzing Commonalities in Clinical Trial Target Populations Zhe (Henry) He 1, Simona Carini 2, Tianyong Hao 1, Ida Sim 2, and Chunhua Weng 1 1 Department of Biomedical Informatics, Columbia

More information

Pathology Of Bone And Joint Disorders Print And Online Bundle With Clinical And Radiographic Correlation

Pathology Of Bone And Joint Disorders Print And Online Bundle With Clinical And Radiographic Correlation Pathology Of Bone And Joint Disorders Print And Online Bundle With Clinical And Radiographic Correlation We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our

More information

Keeping Abreast of Breast Imagers: Radiology Pathology Correlation for the Rest of Us

Keeping Abreast of Breast Imagers: Radiology Pathology Correlation for the Rest of Us SIIM 2016 Scientific Session Quality and Safety Part 1 Thursday, June 30 8:00 am 9:30 am Keeping Abreast of Breast Imagers: Radiology Pathology Correlation for the Rest of Us Linda C. Kelahan, MD, Medstar

More information

Computer based delineation and follow-up multisite abdominal tumors in longitudinal CT studies

Computer based delineation and follow-up multisite abdominal tumors in longitudinal CT studies Research plan submitted for approval as a PhD thesis Submitted by: Refael Vivanti Supervisor: Professor Leo Joskowicz School of Engineering and Computer Science, The Hebrew University of Jerusalem Computer

More information

Organ Procurement and Transplantation Network

Organ Procurement and Transplantation Network OPTN Organ Procurement and Transplantation Network POLICIES This document provides the policy language approved by the OPTN/UNOS Board at its meeting in June 2015 as part of the Operations and Safety Committee

More information

STANDARDS FOR EXAMINING FRICTION RIDGE IMPRESSIONS AND RESULTING CONCLUSIONS (LATENT/TENPRINT)

STANDARDS FOR EXAMINING FRICTION RIDGE IMPRESSIONS AND RESULTING CONCLUSIONS (LATENT/TENPRINT) STANDARDS FOR EXAMINING FRICTION RIDGE IMPRESSIONS AND RESULTING CONCLUSIONS (LATENT/TENPRINT) (To Replace: Friction Ridge Examination Methodology for Latent Print Examiners, ver. 1.01, and Standards for

More information

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath)

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) (See also General Regulations and Regulations for Taught Postgraduate Curricula) M.129 Admission requirements

More information

FUSE TECHNICAL REPORT

FUSE TECHNICAL REPORT FUSE TECHNICAL REPORT 1 / 16 Contents Page 3 Page 4 Page 8 Page 10 Page 13 Page 16 Introduction FUSE Accuracy Validation Testing LBD Risk Score Model Details FUSE Risk Score Implementation Details FUSE

More information

Individual Study Table Referring to Item of the Submission: Volume: Page:

Individual Study Table Referring to Item of the Submission: Volume: Page: 2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:

More information

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. PROPRIETARY DRUG NAME /GENERIC DRUG NAME: Vfend /Voriconazole

More information

Meetings and Presentation Opportunities. Rahul Panesar, MD Associate Professor Division of Critical Care Medicine

Meetings and Presentation Opportunities. Rahul Panesar, MD Associate Professor Division of Critical Care Medicine Meetings and Presentation Opportunities Rahul Panesar, MD Associate Professor Division of Critical Care Medicine Timeline Research Question Do your Homework! Write a Proposal (Background, Question, Study

More information

English 10 Writing Assessment Results and Analysis

English 10 Writing Assessment Results and Analysis Academic Assessment English 10 Writing Assessment Results and Analysis OVERVIEW This study is part of a multi-year effort undertaken by the Department of English to develop sustainable outcomes assessment

More information

Midterm project (Part 2) Due: Monday, November 5, 2018

Midterm project (Part 2) Due: Monday, November 5, 2018 University of Pittsburgh CS3750 Advanced Topics in Machine Learning Professor Milos Hauskrecht Midterm project (Part 2) Due: Monday, November 5, 2018 The objective of the midterm project is to gain experience

More information

Criteria for evaluating transferability of health interventions: a systematic review and thematic synthesis

Criteria for evaluating transferability of health interventions: a systematic review and thematic synthesis Schloemer and Schröder-Bäck Implementation Science (2018) 13:88 https://doi.org/10.1186/s13012-018-0751-8 SYSTEMATIC REVIEW Open Access Criteria for evaluating transferability of health interventions:

More information

IAASB Main Agenda (September 2005) Page Agenda Item. Analysis of ISA 330 and Mapping Document

IAASB Main Agenda (September 2005) Page Agenda Item. Analysis of ISA 330 and Mapping Document IAASB Main Agenda (September 2005 Page 2005 1869 Agenda Item 4-D.1 Analysis of ISA 330 and Mapping Document 1. Exhibit 1 sets out statements in ISA 330 that use the present tense to describe auditor actions,

More information

Health Screenings Overview

Health Screenings Overview Health Screenings Overview 1615 West Chester Pike, Suite 104 West Chester, Pennsylvania 19382 www.wellworksforyou.com 800.425.4657 HEALTHY HEART PACKAGES FINGERSTICK (BIOMETRICS) I. Health Heart Total

More information

Detection and Classification of Lung Cancer Using Artificial Neural Network

Detection and Classification of Lung Cancer Using Artificial Neural Network Detection and Classification of Lung Cancer Using Artificial Neural Network Almas Pathan 1, Bairu.K.saptalkar 2 1,2 Department of Electronics and Communication Engineering, SDMCET, Dharwad, India 1 almaseng@yahoo.co.in,

More information

Positioning the Laboratory to Integrate Clinical Care:

Positioning the Laboratory to Integrate Clinical Care: William G. Morice, M.D., Ph.D. Chair, Division of Hematopathology Mayo Clinic, Rochester, MN Positioning the Laboratory to Integrate Clinical Care: New Approaches to Interactive Test Ordering and Reporting

More information

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI.

PFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See USPI. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall

More information

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.

PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. GENERIC DRUG NAME / COMPOUND NUMBER: Tofacitinib / CP-690,550

More information

Building a Diseases Symptoms Ontology for Medical Diagnosis: An Integrative Approach

Building a Diseases Symptoms Ontology for Medical Diagnosis: An Integrative Approach Building a Diseases Symptoms Ontology for Medical Diagnosis: An Integrative Approach Osama Mohammed, Rachid Benlamri and Simon Fong* Department of Software Engineering, Lakehead University, Ontario, Canada

More information

Bristol-Myers Squibb

Bristol-Myers Squibb A Study of the Safety and Efficacy of plus Tenofovir in Adults with Chronic Hepatitis B Virus Infection with Previous Nucleoside/Nucleotide Treatment Failure () FINAL CLINICAL STUDY REPORT EUDRACT Number:

More information

Empirical Formula for Creating Error Bars for the Method of Paired Comparison

Empirical Formula for Creating Error Bars for the Method of Paired Comparison Empirical Formula for Creating Error Bars for the Method of Paired Comparison Ethan D. Montag Rochester Institute of Technology Munsell Color Science Laboratory Chester F. Carlson Center for Imaging Science

More information

The use of Topic Modeling to Analyze Open-Ended Survey Items

The use of Topic Modeling to Analyze Open-Ended Survey Items The use of Topic Modeling to Analyze Open-Ended Survey Items W. Holmes Finch Maria E. Hernández Finch Constance E. McIntosh Claire Braun Ball State University Open ended survey items Researchers making

More information

Explanation-Boosted Question Selection in Conversational CBR

Explanation-Boosted Question Selection in Conversational CBR Explanation-Boosted Question Selection in Conversational CBR Mingyang Gu and Agnar Aamodt Department of Computer and Information Science, Norwegian University of Science and Technology, Sem Sælands vei

More information

CHAPTER VI RESEARCH METHODOLOGY

CHAPTER VI RESEARCH METHODOLOGY CHAPTER VI RESEARCH METHODOLOGY 6.1 Research Design Research is an organized, systematic, data based, critical, objective, scientific inquiry or investigation into a specific problem, undertaken with the

More information

Letter of Amendment # 3 to:

Letter of Amendment # 3 to: Letter of Amendment # 3 to: HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex with Men (MSM) in the United States Version 1.0, dated 8 October 2015 DAIDS

More information

Semantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS

Semantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS Semantic Alignment between ICD-11 and SNOMED-CT By Marcie Wright RHIA, CHDA, CCS World Health Organization (WHO) owns and publishes the International Classification of Diseases (ICD) WHO was entrusted

More information

Foundations of AI. 10. Knowledge Representation: Modeling with Logic. Concepts, Actions, Time, & All the Rest

Foundations of AI. 10. Knowledge Representation: Modeling with Logic. Concepts, Actions, Time, & All the Rest Foundations of AI 10. Knowledge Representation: Modeling with Logic Concepts, Actions, Time, & All the Rest Wolfram Burgard, Andreas Karwath, Bernhard Nebel, and Martin Riedmiller 10/1 Contents Knowledge

More information

Quantitative survey methods

Quantitative survey methods Quantitative survey methods COECSA, 18 th April 2013, Kampala Dr. Jefitha Karimurio University of Nairobi Outline 1. Introduction 2. Defining the population, 3. Sampling and non-sampling errors, 4. Computation

More information

Subject ID: I N D # # U A * Consent Date: Day Month Year

Subject ID: I N D # # U A * Consent Date: Day Month Year IND Study # Eligibility Checklist Pg 1 of 15 Instructions: Check the appropriate box for each Inclusion and Exclusion Criterion below. Each criterion must be marked and all protocol criteria have to be

More information

Measuring Focused Attention Using Fixation Inner-Density

Measuring Focused Attention Using Fixation Inner-Density Measuring Focused Attention Using Fixation Inner-Density Wen Liu, Mina Shojaeizadeh, Soussan Djamasbi, Andrew C. Trapp User Experience & Decision Making Research Laboratory, Worcester Polytechnic Institute

More information

Survey Research Centre. An Introduction to Survey Research

Survey Research Centre. An Introduction to Survey Research Survey Research Centre An Introduction to Survey Research Outline Introduction to the SRC Beginning with data Two design choices: cross-sectional survey and experiments Coffee break Best practices Your

More information

CASPER COLLEGE MLTK 1500 HI Clinical Hematology and Hemostasis. Lecture Hours: 2 Lab Hours: 4 Credit Hours: 3

CASPER COLLEGE MLTK 1500 HI Clinical Hematology and Hemostasis. Lecture Hours: 2 Lab Hours: 4 Credit Hours: 3 Semester/Year: Fall 2015 CASPER COLLEGE MLTK 1500 HI Clinical Hematology and Hemostasis Lecture Hours: 2 Lab Hours: 4 Credit Hours: 3 Class Time: Lecture Moodle Student Labs: Friday 12-5: 9/11 9/25 10/23

More information

Sonography. 1. Introduction. 2. Documentation of Compliance. 3. Didactic Competency Requirements. 4. Clinical Competency Requirements

Sonography. 1. Introduction. 2. Documentation of Compliance. 3. Didactic Competency Requirements. 4. Clinical Competency Requirements PRIMARY CERTIFICATION Sonography 1. Introduction Candidates for certification and registration are required to meet the Professional Education Requirements specified in the ARRT Rules and Regulations.

More information

The Exploration by Means of Repertory Grids of Semantic Differences Among Names for Office Documents.

The Exploration by Means of Repertory Grids of Semantic Differences Among Names for Office Documents. Syracuse University SURFACE School of Information Studies: Faculty Scholarship School of Information Studies (ischool) 1-1-1992 The Exploration by Means of Repertory Grids of Semantic Differences Among

More information

CHAPTER 6 DESIGN AND ARCHITECTURE OF REAL TIME WEB-CENTRIC TELEHEALTH DIABETES DIAGNOSIS EXPERT SYSTEM

CHAPTER 6 DESIGN AND ARCHITECTURE OF REAL TIME WEB-CENTRIC TELEHEALTH DIABETES DIAGNOSIS EXPERT SYSTEM 87 CHAPTER 6 DESIGN AND ARCHITECTURE OF REAL TIME WEB-CENTRIC TELEHEALTH DIABETES DIAGNOSIS EXPERT SYSTEM 6.1 INTRODUCTION This chapter presents the design and architecture of real time Web centric telehealth

More information

Saudi Health Interview Survey Results. in collaboration with

Saudi Health Interview Survey Results. in collaboration with Saudi Health Interview Survey Results in collaboration with 1 Table of contents Background... 6 Survey objectives... 7 Survey operations... 7 Training... 7 Survey implementation... 8 Survey organization...

More information

Piloting Treatment with IGF-1 in Phelan-McDermid Syndrome

Piloting Treatment with IGF-1 in Phelan-McDermid Syndrome Piloting Treatment with IGF-1 in Phelan-McDermid Syndrome Seaver Autism Center for Research and Treatment at Mount Sinai Principal Investigator: Alex Kolevzon, MD One Gustave L. Levy Place, Box 1230 New

More information

To What Extent Can the Recognition of Unfamiliar Faces be Accounted for by the Direct Output of Simple Cells?

To What Extent Can the Recognition of Unfamiliar Faces be Accounted for by the Direct Output of Simple Cells? To What Extent Can the Recognition of Unfamiliar Faces be Accounted for by the Direct Output of Simple Cells? Peter Kalocsai, Irving Biederman, and Eric E. Cooper University of Southern California Hedco

More information

vertaplan the spine surgeon s software vertaplan System for successful reconstruction of the individual sagittal balance

vertaplan the spine surgeon s software vertaplan System for successful reconstruction of the individual sagittal balance the spine surgeon s software System for successful reconstruction of the individual sagittal balance What do you think of patient-specific reconstruction of the spine geometry? Optimum surgical outcome

More information

Medical Statistics 1. Basic Concepts Farhad Pishgar. Defining the data. Alive after 6 months?

Medical Statistics 1. Basic Concepts Farhad Pishgar. Defining the data. Alive after 6 months? Medical Statistics 1 Basic Concepts Farhad Pishgar Defining the data Population and samples Except when a full census is taken, we collect data on a sample from a much larger group called the population.

More information

Things you need to know about the Normal Distribution. How to use your statistical calculator to calculate The mean The SD of a set of data points.

Things you need to know about the Normal Distribution. How to use your statistical calculator to calculate The mean The SD of a set of data points. Things you need to know about the Normal Distribution How to use your statistical calculator to calculate The mean The SD of a set of data points. The formula for the Variance (SD 2 ) The formula for the

More information

Principal Investigator: Robert J. Jones, MD, Beatson Cancer Center, 1053 Great Western Road, Glasgow; United Kingdom

Principal Investigator: Robert J. Jones, MD, Beatson Cancer Center, 1053 Great Western Road, Glasgow; United Kingdom SYNOPSIS Issue Date: 14 October 2010 Document No.: EDMS-ERI-13494974:2.0 Name of Sponsor/Company Name of Finished Product Name of Active Ingredient(s) Protocol No.: COU-AA-BE Cougar Biotechnology, Inc.

More information

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use

OneTouch Reveal Web Application. User Manual for Healthcare Professionals Instructions for Use OneTouch Reveal Web Application User Manual for Healthcare Professionals Instructions for Use Contents 2 Contents Chapter 1: Introduction...4 Product Overview...4 Intended Use...4 System Requirements...

More information

Innovative Risk and Quality Solutions for Value-Based Care. Company Overview

Innovative Risk and Quality Solutions for Value-Based Care. Company Overview Innovative Risk and Quality Solutions for Value-Based Care Company Overview Meet Talix Talix provides risk and quality solutions to help providers, payers and accountable care organizations address the

More information

T. R. Golub, D. K. Slonim & Others 1999

T. R. Golub, D. K. Slonim & Others 1999 T. R. Golub, D. K. Slonim & Others 1999 Big Picture in 1999 The Need for Cancer Classification Cancer classification very important for advances in cancer treatment. Cancers of Identical grade can have

More information

Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT

Sponsor / Company: Sanofi Drug substance(s): Insulin Glargine. Study Identifiers: NCT These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor / Company: Sanofi Drug substance(s):

More information

Health Screening for Nanyang Technological University (NTU)

Health Screening for Nanyang Technological University (NTU) Health Screening for Nanyang Technological University (NTU) Health screening packages are offered at corporate rates to NTU staff and dependents at the indicated clinics. Please refer to this document

More information

Sponsor: Sanofi Drug substance(s): SAR342434

Sponsor: Sanofi Drug substance(s): SAR342434 These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. Sponsor: Sanofi Drug substance(s):

More information

POPULATION TRACKER - DREAMED USER GUIDE

POPULATION TRACKER - DREAMED USER GUIDE POPULATION TRACKER - DREAMED USER GUIDE November 2018 IFU-0011 05 TABLE OF CONTENTS TABLE OF CONTENTS GENERAL INFORMATION... 1 Product Description... 1 Glooko Intended Use... 1 DreaMed Intended Use...

More information